Isolation of a SIR-like gene, SIR-T8, that is overexpressed in thyroid carcinoma cell lines and tissues

[1]  R. Frye.  ‘SIRT8’ expressed in thyroid cancer is actually SIRT7 , 2002, British Journal of Cancer.

[2]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[3]  C. J. Chen,et al.  PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. , 2000, Science.

[4]  B. Spiegelman,et al.  PAX8-PPARγ1 Fusion in Oncogene Human Thyroid Carcinoma , 2000 .

[5]  R. Frye,et al.  Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. , 2000, Biochemical and biophysical research communications.

[6]  R. Sternglanz,et al.  The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  L. Guarente,et al.  Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase , 2000, Nature.

[8]  D. Moazed,et al.  An Enzymatic Activity in the Yeast Sir2 Protein that Is Essential for Gene Silencing , 1999, Cell.

[9]  M. McVey,et al.  The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. , 1999, Genes & development.

[10]  J. M. Sherman,et al.  The conserved core of a human SIR2 homologue functions in yeast silencing. , 1999, Molecular biology of the cell.

[11]  R. Frye,et al.  Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. , 1999, Biochemical and biophysical research communications.

[12]  J. Murnane,et al.  Telomere dynamics in a human cancer cell line. , 1999, Experimental cell research.

[13]  F. de Nigris,et al.  Overexpression of the HIP gene coding for a heparin/heparan sulfate-binding protein in human thyroid carcinomas. , 1998, Cancer research.

[14]  D. Sereno,et al.  Leishmania major: Cell type dependent distribution of a 43 kDa antigen related to silent information regulatory‐2 protein family , 1998, Biology of the cell.

[15]  G. Viglietto,et al.  Thymosin β-10 Gene Overexpression Correlated with the Highly Malignant Neoplastic Phenotype of Transformed Thyroid Cells in Vivo and in Vitro , 1998 .

[16]  M. P. Miano,et al.  Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFκB p65 protein expression , 1997, Oncogene.

[17]  J. Shay,et al.  A survey of telomerase activity in human cancer. , 1997, European journal of cancer.

[18]  A B Rose,et al.  Hyperactivation of the silencing proteins, Sir2p and Sir3p, causes chromosome loss. , 1997, Genetics.

[19]  M. Borrello,et al.  Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells , 1996, Genes, chromosomes & cancer.

[20]  J. M. Sherman,et al.  The SIR2 gene family, conserved from bacteria to humans, functions in silencing, cell cycle progression, and chromosome stability. , 1995, Genes & development.

[21]  P. Nowell,et al.  Detection of myc translocations in lymphoma cells by fluorescence in situ hybridization with yeast artificial chromosomes. , 1995, Blood.

[22]  G. Chiappetta,et al.  The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. , 1995, Oncogene.

[23]  R. Paro,et al.  Chromatin multiprotein complexes involved in the maintenance of transcription patterns. , 1995, Current opinion in genetics & development.

[24]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[25]  D. Shore,et al.  Evidence that a complex of SIR proteins interacts with the silencer and telomere-binding protein RAP1. , 1994, Genes & development.

[26]  H. Coon,et al.  Long-term culture and functional characterization of follicular cells from adult normal human thyroids. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[27]  C. Harley,et al.  Telomerase activity in human ovarian carcinoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[28]  N. Berger,et al.  Increased expression of the negative growth factor, galactoside-binding protein, gene in transformed thyroid cells and in human thyroid carcinomas. , 1992, Oncogene.

[29]  J. Steitz,et al.  Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. , 1992, The EMBO journal.

[30]  L. Sobin,et al.  The WHO histological classification of thyroid tumors: A commentary on the second edition , 1989, Cancer.

[31]  K. Fujimori,et al.  Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. , 1987, Cancer research.

[32]  J. Hicks,et al.  Cloning and characterization of four SIR genes of Saccharomyces cerevisiae , 1986, Molecular and cellular biology.

[33]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[34]  A. van der Eb,et al.  A new technique for the assay of infectivity of human adenovirus 5 DNA. , 1973, Virology.

[35]  G. Viglietto,et al.  Isolation of a SIR-like gene, SIR-T8, that is overexpressed in thyroid carcinoma cell lines and tissues , 2002, British Journal of Cancer.

[36]  M. White,et al.  Absence of cancer–associated changes in human fibroblasts immortalized with telomerase , 1999, Nature Genetics.

[37]  M. Santoro,et al.  Block of c-myc expression by antisense oligonucleotides inhibits proliferation of human thyroid carcinoma cell lines. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[38]  C. Harley,et al.  Telomerase, cell immortality, and cancer. , 1994, Cold Spring Harbor symposia on quantitative biology.

[39]  H. Sambrook.  Molecular cloning : a laboratory manual. Cold Spring Harbor, NY , 1989 .

[40]  R. Huber,et al.  Transcriptional silencing and longevity protein Sir 2 is an NAD-dependent histone deacetylase , 2022 .